Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ovarian; Mastopathy”

952 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 952 results

Not applicableStudy completedNCT00735150
What this trial is testing

Awareness and Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis for Inherited Breast/Ovarian Cancer Risk

Who this might be right for
Breast CancerOvarian Cancer
Memorial Sloan Kettering Cancer Center 34
Not applicableLooking for participantsNCT05334069
What this trial is testing

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAnn Arbor Stage I Lymphoma+59 more
Alliance for Clinical Trials in Oncology 2,000
Not applicableStudy completedNCT03889171
What this trial is testing

Comparison to Psychological, Medical and Emotional Influencing Communication and Achievement Factors to Oncogenetics Tests

Who this might be right for
CancerColorectal CancerBreast Cancer+1 more
University Hospital, Montpellier 200
Not applicableUnknownNCT02355600
What this trial is testing

Oocyte Recovery During Tamoxifen Adjuvant Therapy

Who this might be right for
Breast Cancer
Instituto de Investigacion Sanitaria La Fe 20
Not applicableStudy completedNCT04902144
What this trial is testing

Clinical Outcomes for Offering Genetic Testing in a Tiered Approach

Who this might be right for
Breast CarcinomaColon CarcinomaMalignant Solid Neoplasm+3 more
Fred Hutchinson Cancer Center 6
Testing effectiveness (Phase 2)Ended earlyNCT02113553
What this trial is testing

Anti-Mullerian Hormone (AMH) as Marker of Ovarian Reserve

Who this might be right for
Breast Cancer
Armando Santoro, MD 45
Not applicableWithdrawnNCT01445275
What this trial is testing

Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199

Who this might be right for
Fallopian Tube CarcinomaHereditary Breast and Ovarian Cancer SyndromeOvarian Carcinoma+1 more
Gynecologic Oncology Group
Not applicableLooking for participantsNCT05649072
What this trial is testing

Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

Who this might be right for
Ovarian CancerBreast CancerColorectal Cancer
M.D. Anderson Cancer Center 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT04503265
What this trial is testing

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant NeoplasmBreast CancerOvarian Cancer+3 more
AtlasMedx, Incorporated 122
Early research (Phase 1)UnknownNCT05273944
What this trial is testing

Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese Patients

Who this might be right for
Breast CancerOvarian Cancer
Shenzhen Kangzhe Pharmaceutical Co., Ltd. 80
Testing effectiveness (Phase 2)Study completedNCT00316407
What this trial is testing

Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer Patients

Who this might be right for
Ovarian Epithelial Cancer Stage IIIStage IV Ovarian CancerStage IV Breast Cancer
Swedish Medical Center 30
Early research (Phase 1)Study completedNCT00001302
What this trial is testing

A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833

Who this might be right for
Breast CancerKidney NeoplasmLymphoma+2 more
National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Study completedNCT00064311
What this trial is testing

Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
National Institutes of Health Clinical Center (CC)
Not applicableAvailableNCT04091295
What this trial is testing

BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast

Who this might be right for
Pancreatic CancerOsteosarcomaMPNST (Malignant Peripheral Nerve Sheath Tumor)+6 more
Aveni Foundation
Testing effectiveness (Phase 2)Study completedNCT00410657
What this trial is testing

Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center 53
Not applicableStudy completedNCT00408681
What this trial is testing

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more
Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT05867251
What this trial is testing

Study of AVZO-021 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorHR+/HER2- Breast CancerHR+, HER2-, Advanced Breast Cancer+6 more
Avenzo Therapeutics, Inc. 430
Not applicableStudy completedNCT05721326
What this trial is testing

Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition

Who this might be right for
Genetic Predisposition to DiseaseBreast Cancer FemaleOvarian Cancer+4 more
Abramson Cancer Center at Penn Medicine 1,283
Not applicableUnknownNCT04066335
What this trial is testing

Study to Evaluate the Safety of Nanoxel M Inj.

Who this might be right for
Breast CancerNon-small Cell Lung CancerProstate Cancer+4 more
Samyang Biopharmaceuticals Corporation 1,498
Early research (Phase 1)Study completedNCT03329950
What this trial is testing

CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Who this might be right for
MelanomaNon-small Cell Lung CancerBreast Cancer+23 more
Celldex Therapeutics 132
Next Page